Review paper
Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker
Abstract
Since most patients with metastatic castration-resistant prostate cancer (mCRPC) have bone metastases, it is important to understand the potential impact of therapies on prognostic biomarkers, such as ALP. Clinical studies involving mCRPC life-prolonging agents (i.e., sipuleucel-T, abiraterone, enzalutamide, docetaxel, cabazitaxel, and radium-223) have shown that baseline ALP level is prognostic for overall survival, and may be a better...
Paper Details
Title
Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker
Published Date
Oct 1, 2018
Journal
Volume
14
Issue
24
Pages
2543 - 2556
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History